OFLOXACIN PHARMACOKINETICS IN RENAL-FAILURE

被引:61
作者
FILLASTRE, JP
LEROY, A
HUMBERT, G
机构
[1] UNIV ROUEN,HOP CHARLES NICOLLE,DEPT BIOCHEM,F-76031 ROUEN,FRANCE
[2] UNIV ROUEN,HOP CHARLES NICOLLE,DEPT NEPHROL,F-76031 ROUEN,FRANCE
关键词
D O I
10.1128/AAC.31.2.156
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:156 / 160
页数:5
相关论文
共 7 条
[1]  
COOPER DC, 1985, ANTIMICROB AGENTS CH, V28, P716
[2]   PHARMACOKINETICS OF NORFLOXACIN IN HEALTHY-VOLUNTEERS AND PATIENTS WITH RENAL AND HEPATIC DAMAGE [J].
EANDI, M ;
VIANO, I ;
DINOLA, F ;
LEONE, L ;
GENAZZANI, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (03) :253-259
[3]   PHARMACOKINETICS OF NORFLOXACIN IN RENAL-FAILURE [J].
FILLASTRE, JP ;
HANNEDOUCHE, T ;
LEROY, A ;
HUMBERT, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (04) :439-439
[4]  
GIBALDI M, 1975, PHARMACOKINETICS
[5]   THE PHARMACOKINETICS AND TISSUE PENETRATION OF OFLOXACIN [J].
LOCKLEY, MR ;
WISE, R ;
DENT, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (06) :647-652
[6]   INVITRO AND INVIVO ACTIVITY OF DL-8280, A NEW OXAZINE DERIVATIVE [J].
SATO, K ;
MATSUURA, Y ;
INOUE, M ;
UNE, T ;
OSADA, Y ;
OGAWA, H ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (04) :548-553
[7]  
VERHO M, 1986, INFECTION S1, V14, P47